Mohammed Shreiba, MD

Dr. Mohammed A. Shreiba, MD of PNS
pns icon fleurdelis

Mohammed Shreiba, MD

Additional Information

Mohammed Shreiba, MD, is a leading Psychiatrist at Pacific Neuropsychiatric Specialists (PNS). He sees psychiatric patients of all ages in the Mission Viejo California location. He has a focus on anxiety, depression, dementia, ADHD, Bipolar Disorder, Adult and Geriatric Psychiatry.

Dr. Shreiba earned his medical degree from University of Aleppo Faculty of Medicine. He received residency training at St. Elizabeth’s Hospital and Southern Illinois Univeristy, holding medical licenses in California, Washington DC, and Illinois. Prior to joining PNS he worked as a psychiatrist in Santa Cruz, CA.

To keep up with the latest advancements in psychiatric care, Dr. Shreiba maintains active membership in a number of professional medical organizations, including the American Medical Association, the American Board of Psychiatry and Neurology, as well as multiple others.

Like most of the PNS team, Dr. Shreiba is fluent in more than one language, speaking English, Arabic, and Russian. He loves working with patients to improve their quality of life.  His wife holds a Doctorate in Molecular Science and they have several children and grandchildren in Orange County.

Learn More

Dr. Shreiba offers Psychiatry in both English, Arabic, and Russian. He works with all mental health patients and is trained in AnxietyADHD, Depression, Alheimer’s, Dementia, Bipolar Disorder, Schizoaffective Disorder, Adult Psychiatry, and Geriatric Psychiatry.  

Top-Trained

We employ top-trained psychologists, psychiatrists, and psychiatric nurse practitioners.

Passionate Team

We've carefully assembled a team whose passion is to serve others with a purpose.

Award Winning

Dr. Alejandro Alva is an award winning and internationally recognized psychiatrist.

Most Renowned

We are Orange County's most renowned psychiatrist practice.

Contact Us

We're Here for You!

Please contact us with questions
or requests for an appointment.
Scroll to Top

Announcing our new partnership with

ATP Clinical Research